Sexual Health & Medical Wellness Artificial Intelligence Is Giving Researchers a New Way to Listen to What Patients Are Saying About Popular GLP-1 Drugs September 13, 2026 Susilo Ahmad The rapid ascent of glucagon-like peptide-1 (GLP-1) receptor agonists—a class of medications including semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound)—has fundamentally altered the landscape of…
Sexual Health & Medical Wellness Unintended Pregnancies Soar as Women on Popular Weight-Loss Medications Overlook Contraception, Raising Alarms Over Fetal Safety June 30, 2026 Susilo Ahmad Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers. This urgent call to action stems…
Psychology & Intimacy Ozempic and Wegovy, Popular Diabetes and Weight-Loss Drugs, Show Surprising Mental Health Benefits in Landmark Study June 3, 2026 Rebecca Shoemaker A groundbreaking new study involving nearly 100,000 individuals has revealed that medications commonly prescribed for type 2 diabetes and obesity, including the widely recognized brands Ozempic and Wegovy, may offer…
